Race Oncology Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.07 |
Market Cap |
AUD4.11 M |
Shares Outstanding |
82.24 M |
Public Float |
65.63 M |
Address |
710 Collins Street Docklands Victoria (VIC) 3008 Australia |
Employees | - |
Website | http://www.raceoncology.com |
Updated | 07/08/2019 |
Race Oncology Ltd is a pharmaceutical company, whose business model is to pursue later stage drug assets, principally in the cancer field. Its first important asset is a chemotherapy drug, called Bisantrene, which is used as the first line of treatment for Acute Myeloid Leukaemia and many other cancers. The company was founded on February 15, 2011 and is headquartered in Docklands, Australia. |